adenosine monophosphate has been researched along with prednisolone in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belton, NR; Sheppard, H; Syme, J; Uttley, WS | 1 |
| Belov, VA | 1 |
| Kawabata, H; Matsuda, K; Nishioka, M; Sasahara, K; Uchida, Y | 1 |
| Eilenberger, J; Fischer, M; Haas, N; Hauck, F; Hermann, M; Huebner, J; Jakob, A; Kappler, M; Kim-Hellmuth, S; Klein, C; Ley-Zaporozhan, J; von Both, U | 1 |
4 other study(ies) available for adenosine monophosphate and prednisolone
| Article | Year |
|---|---|
Calcium balance in children treated with diphosphonates.
Topics: Adenosine Monophosphate; Adrenocorticotropic Hormone; Bone and Bones; Calcinosis; Calcium; Child; Child, Preschool; Dermatomyositis; Etidronic Acid; Feces; Humans; Infant; Infant, Newborn; Magnesium; Male; Organophosphorus Compounds; Phosphorus; Physical Therapy Modalities; Prednisolone; Pseudohypoparathyroidism; Radiography | 1975 |
[Indices of erythrocyte adenyl system in rheumatic patients and their changes in the course of drug therapy].
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Erythrocytes; Humans; Prednisolone; Rheumatic Diseases | 1977 |
Role of energy metabolism in drug-induced acute gastric mucosal injuries in humans.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Diclofenac; Energy Metabolism; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Prednisolone | 2000 |
SARS-CoV-2 Triggering Severe Acute Respiratory Distress Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in a 3-Year-Old Child With Down Syndrome.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Child, Preschool; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Critical Care; Down Syndrome; Genetic Predisposition to Disease; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Lymphohistiocytosis, Hemophagocytic; Male; Prednisolone; SARS-CoV-2; Systemic Inflammatory Response Syndrome | 2021 |